Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Amnesia, Transient Global

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Amnesia, Transient Global in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Amnesia, Transient Global: A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hauw, F1
Meppiel, E1
Steichen, O1
Conan, PL1
Capron, J1
de Broucker, T1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Amnesia, Transient Global

ArticleYear
Isolated persistent acute global amnesia after acute abuse of 3,4-methylenedioxy-methamphetamine (MDMA).
    Journal of the neurological sciences, 2018, 03-15, Volume: 386

    Topics: Adult; Amnesia, Transient Global; Amphetamine-Related Disorders; Cerebral Cortex; Hippocampus; Human

2018